Corporate News 24-Nov-23
Gland Pharma's Pashamylaram unit clears USFDA inspection
Gland Pharma has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection of its Pashamylaram facility in Hyderabad.
Previous News
Benchmarks trade with significant gains; VIX tumbles 9.39%
( Market Commentary - Mid-Session 07-Aug-24 12:36 )
Gland Pharma gains as Q4 PAT soars to Rs 192 cr
( Hot Pursuit - 23-May-24 11:42 )
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
( Hot Pursuit - 07-Aug-24 11:27 )
Gland Pharma gets tentative nod from US FDA for hypotension treatment drug
( Hot Pursuit - 15-Nov-23 12:14 )
Gland Pharma allots 2,400 equity shares under ESOS
( Corporate News - 26-Mar-24 09:55 )
Volumes jump at Gland Pharma Ltd counter
( Hot Pursuit - 23-May-24 11:00 )
Gland Pharma to hold AGM
( Corporate News - 23-May-24 09:38 )
Board of Gland Pharma recommends final dividend
( Corporate News - 23-May-24 09:38 )
Gland Pharma
( Results - Analysis 07-Nov-23 10:30 )
Gland Pharma announces board meeting date
( Corporate News - 28-Jul-23 11:39 )
Gland Pharma Ltd spurts 3.45%, gains for third straight session
( Hot Pursuit - 09-Jul-24 13:06 )
Other Stories
Anmol India to conduct board meeting
03-Oct-24 10:07
KPI Green Energy receives CEIG approval for 5 MW solar power project
03-Oct-24 10:04
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Back
Top
